SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-027354
Filing Date
2021-11-05
Accepted
2021-11-05 16:05:42
Documents
15
Period of Report
2021-11-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 38347
2 ex4-1.htm EX-4.1 80645
3 ex4-2.htm EX-4.2 83612
4 ex10-1.htm EX-10.1 202005
  Complete submission text file 0001493152-21-027354.txt   658259

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE obmp-20211101.xsd EX-101.SCH 3027
6 XBRL LABEL FILE obmp-20211101_lab.xml EX-101.LAB 34239
7 XBRL PRESENTATION FILE obmp-20211101_pre.xml EX-101.PRE 22360
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3390
Mailing Address 8000 INNOVATION PARK DR, BATON ROUGE BATON ROUGE LA 70820
Business Address 8000 INNOVATION PARK DR, BATON ROUGE BATON ROUGE LA 70820 225-578-7555
THERALINK TECHNOLOGIES, INC. (Filer) CIK: 0001362703 (see all company filings)

IRS No.: 202590810 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-52218 | Film No.: 211384510
SIC: 2834 Pharmaceutical Preparations